{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:27:55Z","timestamp":1792801675109,"version":"4.5.0"},"reference-count":244,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.phrs.2024.107410","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T21:02:23Z","timestamp":1726174943000},"page":"107410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Role of histone deacetylases and their inhibitors in neurological diseases"],"prefix":"10.1016","volume":"208","author":[{"given":"Li-Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tie-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.phrs.2024.107410_bib1","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.2174\/1389557522666220330144151","article-title":"The zinc-dependent HDACs: non-histone substrates and catalytic deacylation beyond deacetylation","volume":"22","author":"Zheng","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107410_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117278","article-title":"Pharmacological intervention of histone deacetylase enzymes in the neurodegenerative disorders","volume":"243","author":"Gupta","year":"2020","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2024.107410_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib6","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1128\/MCB.25.8.2873-2884.2005","article-title":"Class II histone deacetylases: from sequence to function, regulation, and clinical implication","volume":"25","author":"Yang","year":"2005","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107410_bib7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","article-title":"HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0006-291X(69)90661-5","article-title":"Enzymatic deacetylation of histone","volume":"36","author":"Inoue","year":"1969","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd772","article-title":"Histone-deacetylase inhibitors: novel drugs for the treatment of cancer","volume":"1","author":"Johnstone","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12964-018-0231-4","article-title":"Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6","volume":"16","author":"Vanaja","year":"2018","journal-title":"Cell Commun. Signal"},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0002-9440(10)63320-2","article-title":"Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues","volume":"165","author":"Waltregny","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"28","key":"10.1016\/j.phrs.2024.107410_bib12","doi-asserted-by":"crossref","first-page":"25748","DOI":"10.1074\/jbc.M111871200","article-title":"Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family","volume":"277","author":"Gao","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2024.107410_bib13","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/nar\/30.5.1114","article-title":"X.-J. Yang, Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain","volume":"30","author":"Tong","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"6887","key":"10.1016\/j.phrs.2024.107410_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.phrs.2024.107410_bib15","doi-asserted-by":"crossref","first-page":"10572","DOI":"10.1073\/pnas.191375098","article-title":"Cloning and characterization of a histone deacetylase, HDAC9","volume":"98","author":"Zhou","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.phrs.2024.107410_bib16","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.febslet.2010.02.057","article-title":"Protein kinase C-related kinase targets nuclear localization signals in a subset of class IIa histone deacetylases","volume":"584","author":"Harrison","year":"2010","journal-title":"FEBS Lett."},{"issue":"16","key":"10.1016\/j.phrs.2024.107410_bib17","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1093\/nar\/29.16.3439","article-title":"T. Kouzarides, Differential localization of HDAC4 orchestrates muscle differentiation","volume":"29","author":"Miska","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"37","key":"10.1016\/j.phrs.2024.107410_bib18","doi-asserted-by":"crossref","first-page":"35042","DOI":"10.1074\/jbc.M105086200","article-title":"The modular nature of histone deacetylase HDAC4 confers phosphorylation-dependent intracellular trafficking","volume":"276","author":"Zhao","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2024.107410_bib19","doi-asserted-by":"crossref","first-page":"C1029","DOI":"10.1152\/ajpcell.00059.2006","article-title":"Shuttling of HDAC5 in H9C2 cells regulates YY1 function through CaMKIV\/PKD and PP2A","volume":"291","author":"Sucharov","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6808","key":"10.1016\/j.phrs.2024.107410_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/35040593","article-title":"Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation","volume":"408","author":"McKinsey","year":"2000","journal-title":"Nature"},{"issue":"50","key":"10.1016\/j.phrs.2024.107410_bib21","doi-asserted-by":"crossref","first-page":"47496","DOI":"10.1074\/jbc.M107631200","article-title":"Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7","volume":"276","author":"Kao","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"33","key":"10.1016\/j.phrs.2024.107410_bib22","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M405179200","article-title":"Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib23","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cr.2017.68","article-title":"Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription","volume":"27","author":"Wei","year":"2017","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-017-02651-5","article-title":"Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases","volume":"9","author":"Fellows","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32927-9","article-title":"Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo","volume":"8","author":"Kelly","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41421-023-00573-9","article-title":"HDAC1\/2\/3 are major histone desuccinylases critical for promoter desuccinylation","volume":"9","author":"Li","year":"2023","journal-title":"Cell Discov."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/cr.2017.149","article-title":"Landscape of the regulatory elements for lysine 2-hydroxyisobutyrylation pathway","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res"},{"issue":"12","key":"10.1016\/j.phrs.2024.107410_bib28","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/s41589-021-00875-7","article-title":"Dynamic crotonylation of EB1 by TIP60 ensures accurate spindle positioning in mitosis","volume":"17","author":"Song","year":"2021","journal-title":"Nat. Chem. Biol."},{"issue":"36","key":"10.1016\/j.phrs.2024.107410_bib29","doi-asserted-by":"crossref","first-page":"9083","DOI":"10.1002\/anie.201203754","article-title":"Profiling of substrates for zinc-dependent lysine deacylase enzymes: HDAC3 exhibits decrotonylase activity in vitro","volume":"51","author":"Madsen","year":"2012","journal-title":"Angew. Chem. Int Ed. Engl."},{"issue":"10","key":"10.1016\/j.phrs.2024.107410_bib30","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/acschembio.6b00396","article-title":"HDAC8 Catalyzes the Hydrolysis of Long Chain Fatty Acyl Lysine","volume":"11","author":"Aramsangtienchai","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2018.04.007","article-title":"Histone deacetylase 11 is an \u03b5-N-Myristoyllysine Hydrolase","volume":"25","author":"Moreno-Yruela","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1021\/acschembio.7b00942","article-title":"Histone deacetylase 11 is a fatty-acid deacylase","volume":"13","author":"Kutil","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bpj.2016.11.015","article-title":"Histone acetylation regulates chromatin accessibility: role of H4K16 in inter-nucleosome interaction","volume":"112","author":"Zhang","year":"2017","journal-title":"Biophys. J."},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrm.2017.26","article-title":"Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes","volume":"18","author":"Clapier","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081179","article-title":"The NuRD complex in neurodevelopment and disease: a case of sliding doors","volume":"12","author":"Boulasiki","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib36","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/acs.chemrev.7b00181","article-title":"Lysine acetylation goes global: from epigenetics to metabolism and therapeutics","volume":"118","author":"Ali","year":"2018","journal-title":"Chem. Rev."},{"issue":"5968","key":"10.1016\/j.phrs.2024.107410_bib37","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.1179689","article-title":"Regulation of cellular metabolism by protein lysine acetylation","volume":"327","author":"Zhao","year":"2010","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.phrs.2024.107410_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01894-17","article-title":"Ancient regulatory role of lysine acetylation in central metabolism","volume":"8","author":"Nakayasu","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.phrs.2024.107410_bib39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cbpa.2015.10.030","article-title":"Metabolic control of methylation and acetylation","volume":"30","author":"Su","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"17","key":"10.1016\/j.phrs.2024.107410_bib40","doi-asserted-by":"crossref","first-page":"12142","DOI":"10.1074\/jbc.M112.428318","article-title":"Quantitative dynamics of the link between cellular metabolism and histone acetylation","volume":"288","author":"Evertts","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tibs.2015.12.006","article-title":"Mechanisms and dynamics of protein acetylation in mitochondria","volume":"41","author":"Baeza","year":"2016","journal-title":"Trends Biochem Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib42","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1038\/s41467-023-42342-y","article-title":"N-terminal acetylation shields proteins from degradation and promotes age-dependent motility and longevity","volume":"14","author":"Varland","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib43","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.molcel.2011.05.004","article-title":"Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes","volume":"42","author":"Cai","year":"2011","journal-title":"Mol. Cell"},{"issue":"14","key":"10.1016\/j.phrs.2024.107410_bib44","doi-asserted-by":"crossref","first-page":"17978","DOI":"10.18632\/aging.203304","article-title":"HDAC2 and 7 down-regulation induces senescence in dermal fibroblasts","volume":"13","author":"Warnon","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"10","key":"10.1016\/j.phrs.2024.107410_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165836","article-title":"Acetylation in cardiovascular diseases: molecular mechanisms and clinical implications","volume":"1866","author":"Yang","year":"2020","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"23","key":"10.1016\/j.phrs.2024.107410_bib46","doi-asserted-by":"crossref","first-page":"10333","DOI":"10.1523\/JNEUROSCI.22-23-10333.2002","article-title":"Histone deacetylase activity is necessary for oligodendrocyte lineage progression","volume":"22","author":"Marin-Husstege","year":"2002","journal-title":"J. Neurosci."},{"issue":"1-2","key":"10.1016\/j.phrs.2024.107410_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.diff.2012.12.001","article-title":"Histone deacetylase inhibitor Trichostatin A induces neural tube defects and promotes neural crest specification in the chicken neural tube","volume":"85","author":"Murko","year":"2013","journal-title":"Differentiation"},{"key":"10.1016\/j.phrs.2024.107410_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2164-12-24","article-title":"The epigenetic regulator Histone Deacetylase 1 promotes transcription of a core neurogenic programme in zebrafish embryos","volume":"12","author":"Harrison","year":"2011","journal-title":"BMC Genom."},{"issue":"11","key":"10.1016\/j.phrs.2024.107410_bib49","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/emboj\/21.11.2672","article-title":"Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression","volume":"21","author":"Lagger","year":"2002","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nn.2780","article-title":"HDAC-mediated deacetylation of NF-\u03baB is critical for Schwann cell myelination","volume":"14","author":"Chen","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2024.107410_bib51","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1242\/dev.01166","article-title":"Histone deacetylase 1 is required to repress Notch target gene expression during zebrafish neurogenesis and to maintain the production of motoneurones in response to hedgehog signalling","volume":"131","author":"Cunliffe","year":"2004","journal-title":"Development"},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib52","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/dvdy.21626","article-title":"Histone deacetylases 1 and 2 are expressed at distinct stages of neuro-glial development","volume":"237","author":"MacDonald","year":"2008","journal-title":"Dev. Dyn."},{"issue":"1-2","key":"10.1016\/j.phrs.2024.107410_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(03)00545-7","article-title":"Upregulation of class II histone deacetylases mRNA during neural differentiation of cultured rat hippocampal progenitor cells","volume":"346","author":"Ajamian","year":"2003","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cell.2008.11.050","article-title":"A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons","volume":"136","author":"Kim","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107410_bib55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.conb.2014.03.008","article-title":"HDAC signaling in neuronal development and axon regeneration","volume":"27","author":"Cho","year":"2014","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib56","first-page":"31","article-title":"HDAC9 is implicated in schizophrenia and expressed specifically in post-mitotic neurons but not in adult neural stem cells","volume":"1","author":"Lang","year":"2012","journal-title":"Am. J. Stem Cells"},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib57","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nchembio.95","article-title":"Small-molecule activation of neuronal cell fate","volume":"4","author":"Schneider","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"41","key":"10.1016\/j.phrs.2024.107410_bib58","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.1523\/JNEUROSCI.1826-05.2005","article-title":"Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death","volume":"25","author":"Bolger","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107410_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.114660","article-title":"Low expression of the intestinal metabolite butyric acid and the corresponding memory pattern regulate HDAC4 to promote apoptosis in rat hippocampal neurons","volume":"253","author":"Xu","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jnr.21521","article-title":"Developmental expression of histone deacetylase 11 in the murine brain","volume":"86","author":"Liu","year":"2008","journal-title":"J. Neurosci. Res"},{"issue":"7243","key":"10.1016\/j.phrs.2024.107410_bib61","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature07925","article-title":"HDAC2 negatively regulates memory formation and synaptic plasticity","volume":"459","author":"Guan","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12760","article-title":"Memory and plasticity impairment after binge drinking in adolescent rat hippocampus: GluN2A\/GluN2B NMDA receptor subunits imbalance through HDAC2","volume":"25","author":"Drissi","year":"2020","journal-title":"Addict. Biol."},{"issue":"25","key":"10.1016\/j.phrs.2024.107410_bib63","doi-asserted-by":"crossref","first-page":"8288","DOI":"10.1523\/JNEUROSCI.0097-09.2009","article-title":"Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function","volume":"29","author":"Akhtar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107410_bib64","doi-asserted-by":"crossref","first-page":"16616","DOI":"10.1038\/srep16616","article-title":"Histone deacetylase 3 inhibition re-establishes synaptic tagging and capture in aging through the activation of nuclear factor kappa B","volume":"5","author":"Sharma","year":"2015","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.phrs.2024.107410_bib65","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1093\/nar\/gky573","article-title":"Rpd3L HDAC links H3K4me3 to transcriptional repression memory","volume":"46","author":"Lee","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib66","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00018-009-0242-9","article-title":"Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3","volume":"67","author":"Jung","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phrs.2024.107410_bib67","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.freeradbiomed.2023.08.023","article-title":"Melatonin ameliorates histone modification disorders in mammalian aged oocytes by neutralizing the alkylation of HDAC1","volume":"208","author":"He","year":"2023","journal-title":"Free Radic. Biol. Med"},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib68","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1007\/s12035-017-0490-x","article-title":"Histone deacetylase 2 inhibition attenuates downregulation of hippocampal plasticity gene expression during aging","volume":"55","author":"Singh","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.phrs.2024.107410_bib69","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.18632\/aging.204118","article-title":"Histone deacetylase 4 reverses cellular senescence via DDIT4 in dermal fibroblasts","volume":"14","author":"Lee","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.nbd.2011.07.001","article-title":"What have we learned from gene expression profiles in Huntington's disease?","volume":"45","author":"Seredenina","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2024.107410_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.phrs.2015.08.002","article-title":"Transcriptional dysregulation in Huntington's disease: the role of histone deacetylases","volume":"100","author":"Sharma","year":"2015","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107410_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1172","article-title":"Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6\/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model","volume":"2","author":"Quinti","year":"2010","journal-title":"PLoS Curr."},{"key":"10.1016\/j.phrs.2024.107410_bib73","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainres.2013.02.012","article-title":"Histone deacetylase class II and acetylated core histone immunohistochemistry in human brains with Huntington's disease","volume":"1504","author":"Yeh","year":"2013","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.phrs.2024.107410_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001717","article-title":"HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration","volume":"11","author":"Mielcarek","year":"2013","journal-title":"PLoS Biol."},{"issue":"8 suppl 1","key":"10.1016\/j.phrs.2024.107410_bib75","article-title":"Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics","volume":"18","author":"Federspiel","year":"2019","journal-title":"Mol. Cell. Proteom.\u00a0MCP"},{"issue":"13","key":"10.1016\/j.phrs.2024.107410_bib76","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","article-title":"Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation","volume":"27","author":"Dompierre","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2024.107410_bib77","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-8-7","article-title":"HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?","volume":"8","author":"Sim\u00f5es-Pires","year":"2013","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.phrs.2024.107410_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020696","article-title":"Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Bobrowska","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2024.107410_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.616886","article-title":"The effects of selective inhibition of histone deacetylase 1 and 3 in Huntington's disease mice","volume":"14","author":"Hecklau","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2024.107410_bib80","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1021\/pr500514r","article-title":"Quantitative proteomic analysis identifies targets and pathways of a 2-aminobenzamide HDAC inhibitor in Friedreich's ataxia patient iPSC-derived neural stem cells","volume":"13","author":"Shan","year":"2014","journal-title":"J. Proteome Res"},{"issue":"11","key":"10.1016\/j.phrs.2024.107410_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027746","article-title":"SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington's disease","volume":"6","author":"Mielcarek","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib82","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nbd.2012.01.016","article-title":"Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease","volume":"46","author":"Jia","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"10284","key":"10.1016\/j.phrs.2024.107410_bib83","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.phrs.2024.107410_bib84","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer's disease facts and figures, Alzheimers Dement 19(4) (2023) 1598-1695.","DOI":"10.1002\/alz.13016"},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/genes14020347","article-title":"Histone Modifications in Alzheimer's Disease","volume":"14","author":"Santana","year":"2023","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib86","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","article-title":"Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective","volume":"20","author":"Kumar","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib87","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/1533317513500838","article-title":"Gene expression profile and functional analysis of Alzheimer's disease","volume":"28","author":"Chen","year":"2013","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"key":"10.1016\/j.phrs.2024.107410_bib88","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fnagi.2018.00137","article-title":"Histone deacetylase inhibitor alleviates the neurodegenerative phenotypes and histone dysregulation in presenilins-deficient mice","volume":"10","author":"Cao","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.phrs.2024.107410_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137533","article-title":"Histone deacetylase inhibitor attenuates the effects of 27-hydroxycholesterol on the rat brain","volume":"818","author":"Chen","year":"2024","journal-title":"Neurosci. Lett."},{"issue":"16","key":"10.1016\/j.phrs.2024.107410_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168633","article-title":"Evaluation of Class IIa histone deacetylases expression and in vivo epigenetic imaging in a transgenic mouse model of Alzheimer's Disease","volume":"22","author":"Chen","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib91","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JAD-140066","article-title":"Tubastatin A\/ACY-1215 improves cognition in Alzheimer's disease transgenic mice","volume":"41","author":"Zhang","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib92","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/emmm.201201923","article-title":"Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease","volume":"5","author":"Govindarajan","year":"2013","journal-title":"EMBO Mol. Med"},{"issue":"19","key":"10.1016\/j.phrs.2024.107410_bib93","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1523\/JNEUROSCI.0260-15.2015","article-title":"ApoE4 and A\u03b2 oligomers reduce BDNF expression via HDAC nuclear translocation","volume":"35","author":"Sen","year":"2015","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib94","article-title":"Structure-based discovery of A small molecule inhibitor of histone deacetylase 6 (HDAC6) that significantly reduces Alzheimer's disease neuropathology","volume":"11","author":"Mondal","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/alzrt259","article-title":"Acetylation: a new key to unlock tau's role in neurodegeneration","volume":"6","author":"Cook","year":"2014","journal-title":"Alzheimers Res Ther."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib96","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-2012-121009","article-title":"Loss of HDAC5 impairs memory function: implications for Alzheimer's disease","volume":"33","author":"Agis-Balboa","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.phrs.2024.107410_bib97","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/acel.12642","article-title":"HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease","volume":"16","author":"Zhu","year":"2017","journal-title":"Aging Cell"},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13895","article-title":"Reduction of class I histone deacetylases ameliorates ER-mitochondria cross-talk in Alzheimer's disease","volume":"22","author":"Marinho","year":"2023","journal-title":"Aging Cell"},{"issue":"7388","key":"10.1016\/j.phrs.2024.107410_bib99","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10849","article-title":"An epigenetic blockade of cognitive functions in the neurodegenerating brain","volume":"483","author":"Gr\u00e4ff","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phrs.2024.107410_bib100","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.celrep.2017.07.044","article-title":"The transcription factor Sp3 cooperates with HDAC2 to regulate synaptic function and plasticity in neurons","volume":"20","author":"Yamakawa","year":"2017","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib101","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nn.3618","article-title":"Epigenetic suppression of neuroligin 1 underlies amyloid-induced memory deficiency","volume":"17","author":"Bie","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib102","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1039\/D0FO00161A","article-title":"Up-regulation of neprilysin mediates the protection of fructo-oligosaccharides against Alzheimer's disease","volume":"11","author":"Wu","year":"2020","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib103","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1038\/s41467-022-30653-5","article-title":"[11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's disease","volume":"13","author":"Pascoal","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib104","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/nan.12518","article-title":"HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease","volume":"45","author":"Mahady","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107410_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.782206","article-title":"Histone deacetylase inhibitor improves the dysfunction of hippocampal gamma oscillations and fast spiking interneurons in Alzheimer's Disease Model Mice","volume":"14","author":"Takasu","year":"2021","journal-title":"Front. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2024.107410_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102649","article-title":"TFEB acetylation promotes lysosome biogenesis and ameliorates Alzheimer's disease-relevant phenotypes in mice","volume":"298","author":"Li","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"3 (","key":"10.1016\/j.phrs.2024.107410_bib107","article-title":"Therapeutic targeting of histone deacetylation to prevent Alzheimer's disease","author":"Chacko","year":"2021","journal-title":"Emed. Res."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib108","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2011-110080","article-title":"Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression","volume":"26","author":"Govindarajan","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"28","key":"10.1016\/j.phrs.2024.107410_bib109","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.2174\/1381612811319280003","article-title":"Histone acetylation in neurodevelopment","volume":"19","author":"Contestabile","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.phrs.2024.107410_bib110","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/hipo.20883","article-title":"Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease","volume":"22","author":"Ricobaraza","year":"2012","journal-title":"Hippocampus"},{"issue":"5","key":"10.1016\/j.phrs.2024.107410_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054805","article-title":"Selective Targeting of Class I HDAC Reduces Microglial Inflammation in the Entorhinal Cortex of Young APP\/PS1 Mice","volume":"24","author":"Wang","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107410_bib112","doi-asserted-by":"crossref","DOI":"10.1177\/1533317519883496","article-title":"\u03b2-Hydroxybutyrate Ameliorates A\u03b2-Induced Downregulation of TrkA Expression by Inhibiting HDAC1\/3 in SH-SY5Y Cells","volume":"35","author":"Li","year":"2020","journal-title":"Am. J. Alzheimers Dis. Other Demen"},{"issue":"13","key":"10.1016\/j.phrs.2024.107410_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134160","article-title":"A Class I HDAC inhibitor rescues synaptic damage and neuron loss in APP-transfected cells and APP\/PS1 mice through the GRIP1\/AMPA Pathway","volume":"27","author":"Han","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib114","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease","volume":"35","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107410_bib115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuroscience.2014.02.012","article-title":"Age-dependent effects of valproic acid in Alzheimer's disease (AD) mice are associated with nerve growth factor (NGF) regulation","volume":"266","author":"Noh","year":"2014","journal-title":"Neuroscience"},{"issue":"1-2","key":"10.1016\/j.phrs.2024.107410_bib116","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.lfs.2014.01.064","article-title":"Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease","volume":"99","author":"Yang","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2024.107410_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110429","article-title":"Assessment of suberoylanilide hydroxamic acid on a Alzheimer's disease model induced by \u03b2-amyloid(1-42) in aged female mice: neuromodulatory and epigenetic effect","volume":"375","author":"Athaide Rocha","year":"2023","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.phrs.2024.107410_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109452","article-title":"Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice","volume":"341","author":"Jiang","year":"2021","journal-title":"Chem. Biol. Inter."},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib119","doi-asserted-by":"crossref","first-page":"621","DOI":"10.18632\/aging.100683","article-title":"D-beta-hydroxybutyrate extends lifespan in C. elegans","volume":"6","author":"Edwards","year":"2014","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.phrs.2024.107410_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113821","article-title":"Synthesis and biological evaluation of selective histone deacetylase 6 inhibitors as multifunctional agents against Alzheimer's disease","volume":"225","author":"Wang","year":"2021","journal-title":"Eur. J. Med Chem."},{"issue":"9996","key":"10.1016\/j.phrs.2024.107410_bib121","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"9423","key":"10.1016\/j.phrs.2024.107410_bib122","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci13040670","article-title":"Histone deacetylase 4 inhibition reduces rotenone-induced alpha-synuclein accumulation via autophagy in SH-SY5Y Cells","volume":"13","author":"Wang","year":"2023","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib124","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1007\/s12035-018-1206-6","article-title":"Impaired mitophagy and protein acetylation levels in fibroblasts from Parkinson's disease patients","volume":"56","author":"Yakhine-Diop","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"22","key":"10.1016\/j.phrs.2024.107410_bib125","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1523\/JNEUROSCI.1419-21.2022","article-title":"CREB inactivation by HDAC1\/PP1\u03b3 contributes to dopaminergic neurodegeneration in Parkinson's disease","volume":"42","author":"Xu","year":"2022","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib126","first-page":"267","article-title":"Mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson's Disease","volume":"12","author":"Domenighetti","year":"2022","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.phrs.2024.107410_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104154","article-title":"Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of Mendelian randomization studies","volume":"82","author":"Larsson","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.phrs.2024.107410_bib128","article-title":"Entinostat improves motor function and neuronal damage via downregulating nlrp3 inflammasome activation after spinal cord","volume":"12","author":"Dai","year":"2021","journal-title":"Inj., Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib129","first-page":"1682","article-title":"Increased HDAC3 and decreased miRNA-130a expression in PBMCs through recruitment HDAC3 in patients with spinal cord injuries","volume":"8","author":"Ma","year":"2015","journal-title":"Int J. Clin. Exp. Pathol."},{"key":"10.1016\/j.phrs.2024.107410_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118098","article-title":"miR-27a promotion resulting from silencing of HDAC3 facilitates the recovery of spinal cord injury by inhibiting PAK6 expression in rats","volume":"260","author":"Zhou","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib131","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12974-018-1193-6","article-title":"Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3","volume":"15","author":"Chen","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.phrs.2024.107410_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116819","article-title":"Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p\/HDAC2","volume":"235","author":"Guo","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib133","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-022-02563-2","article-title":"Microglia-specific deletion of histone deacetylase 3 promotes inflammation resolution, white matter integrity, and functional recovery in a mouse model of traumatic brain injury","volume":"19","author":"Zhao","year":"2022","journal-title":"J. Neuroinflamm."},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18485","article-title":"HDAC inhibitor attenuates rat traumatic brain injury induced neurological impairments","volume":"9","author":"Lu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.phrs.2024.107410_bib135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fnmol.2018.00117","article-title":"Valproic acid attenuates traumatic brain injury-induced inflammation in vivo: involvement of autophagy and the Nrf2\/ARE Signaling Pathway","volume":"11","author":"Chen","year":"2018","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib136","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/TA.0000000000002119","article-title":"Isoform 6-selective histone deacetylase inhibition reduces lesion size and brain swelling following traumatic brain injury and hemorrhagic shock","volume":"86","author":"Nikolian","year":"2019","journal-title":"J. Trauma Acute Care Surg."},{"issue":"6","key":"10.1016\/j.phrs.2024.107410_bib137","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib138","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jcmm.12040","article-title":"HDAC4\/5-HMGB1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia\/reperfusion injury","volume":"17","author":"He","year":"2013","journal-title":"J. Cell Mol. Med"},{"issue":"6","key":"10.1016\/j.phrs.2024.107410_bib139","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/jcmm.12803","article-title":"HDAC9 exacerbates endothelial injury in cerebral ischaemia\/reperfusion injury","volume":"20","author":"Shi","year":"2016","journal-title":"J. Cell Mol. Med"},{"issue":"6","key":"10.1016\/j.phrs.2024.107410_bib140","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02406.x","article-title":"Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction","volume":"89","author":"Ren","year":"2004","journal-title":"J. Neurochem"},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib141","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.expneurol.2007.11.031","article-title":"Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury","volume":"210","author":"Yildirim","year":"2008","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib142","first-page":"206","article-title":"HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation","volume":"6","author":"Kim","year":"2014","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib143","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1124\/mol.104.001339","article-title":"Sodium 4-phenylbutyrate protects against cerebral ischemic injury","volume":"66","author":"Qi","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.phrs.2024.107410_bib144","article-title":"Pilocarpine-induced seizures associate with modifications of LSD1\/CoREST\/HDAC1\/2 epigenetic complex and repressive chromatin in mice hippocampus","volume":"25","author":"Noches","year":"2021","journal-title":"Biochem Biophys. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib145","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10571-020-00994-0","article-title":"Role of altered expression, activity and sub-cellular distribution of various histone deacetylases (HDACs) in mesial temporal lobe epilepsy with hippocampal sclerosis","volume":"42","author":"Srivastava","year":"2022","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107410_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2015.07.026","article-title":"Rapid changes in expression of class I and IV histone deacetylases during epileptogenesis in mouse models of temporal lobe epilepsy","volume":"273","author":"Jagirdar","year":"2015","journal-title":"Exp. Neurol."},{"issue":"37","key":"10.1016\/j.phrs.2024.107410_bib147","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.2174\/1381612823666171024130001","article-title":"Role of histone deacetylases (HDACs) in epilepsy and epileptogenesis","volume":"23","author":"Citraro","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib148","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/jnc.13440","article-title":"Expression of class II histone deacetylases in two mouse models of temporal lobe epilepsy","volume":"136","author":"Jagirdar","year":"2016","journal-title":"J. Neurochem"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib149","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.117.244939","article-title":"Epigenetic histone deacetylation inhibition prevents the development and persistence of temporal lobe epilepsy","volume":"364","author":"Reddy","year":"2018","journal-title":"J. Pharm. Exp. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pnpbp.2012.01.017","article-title":"Valproic acid mediates the synaptic excitatory\/inhibitory balance through astrocytes--a preliminary study","volume":"37","author":"Wang","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"22","key":"10.1016\/j.phrs.2024.107410_bib151","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1523\/JNEUROSCI.0110-07.2007","article-title":"Epigenetic modulation of seizure-induced neurogenesis and cognitive decline","volume":"27","author":"Jessberger","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib152","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12035-019-01712-8","article-title":"Effects of histone deacetylase inhibitors on the development of epilepsy and psychiatric comorbidity in WAG\/Rij Rats","volume":"57","author":"Citraro","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107410_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.549191","article-title":"Pain Modulation in WAG\/Rij epileptic rats (a genetic model of absence epilepsy): effects of biological and pharmacological histone deacetylase inhibitors","volume":"11","author":"De Caro","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib154","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","article-title":"Spinal muscular atrophy","volume":"8","author":"Mercuri","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"15","key":"10.1016\/j.phrs.2024.107410_bib155","article-title":"Spinal muscular atrophy: the past,\u00a0present, and future of diagnosis and treatment","volume":"24","author":"Nishio","year":"2023","journal-title":"Present, Future Diagn. Treat., Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2024.107410_bib156","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1212\/WNL.0000000000201654","article-title":"Prevalence of spinal muscular atrophy in the era of disease-modifying therapies: an Italian nationwide survey","volume":"100","author":"Coratti","year":"2023","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib157","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009715","article-title":"Prenusinersen economic and health-related quality of life burden of spinal muscular atrophy","volume":"95","author":"Chambers","year":"2020","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib158","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","article-title":"A multi-source approach to determine SMA incidence and research ready population","volume":"264","author":"Verhaart","year":"2017","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib159","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition","volume":"18","author":"Hauke","year":"2009","journal-title":"Hum. Mol. Genet"},{"issue":"9","key":"10.1016\/j.phrs.2024.107410_bib160","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddi130","article-title":"The role of histone acetylation in SMN gene expression","volume":"14","author":"Kernochan","year":"2005","journal-title":"Hum. Mol. Genet"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib161","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbrc.2011.09.011","article-title":"Differential regulation of the SMN2 gene by individual HDAC proteins","volume":"414","author":"Evans","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib162","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-4159.2006.03868.x","article-title":"In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy","volume":"98","author":"Hahnen","year":"2006","journal-title":"J. Neurochem"},{"issue":"9","key":"10.1016\/j.phrs.2024.107410_bib163","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/jhg.2016.61","article-title":"Transcript, methylation and molecular docking analyses of the effects of HDAC inhibitors, SAHA and Dacinostat, on SMN2 expression in fibroblasts of SMA patients","volume":"61","author":"Mohseni","year":"2016","journal-title":"J. Hum. Genet"},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib164","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/pr1005263","article-title":"Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells","volume":"9","author":"Fuller","year":"2010","journal-title":"J. Proteome Res"},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nbd.2009.08.014","article-title":"Valproic acid blocks excitability in SMA type I mouse motor neurons","volume":"36","author":"Rak","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"6 Suppl 4","key":"10.1016\/j.phrs.2024.107410_bib166","first-page":"S218","article-title":"ALS","volume":"47","author":"Jerusalem","year":"1996","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.phrs.2024.107410_bib167","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/17482961003610853","article-title":"The sex ratio in amyotrophic lateral sclerosis: a population based study","volume":"11","author":"Manjaly","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib168","doi-asserted-by":"crossref","first-page":"1311.e7","DOI":"10.1016\/j.neurobiolaging.2012.09.004","article-title":"Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis","volume":"34","author":"Jang","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2024.107410_bib169","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ebiom.2019.01.038","article-title":"Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis","volume":"40","author":"Pigna","year":"2019","journal-title":"EBioMedicine"},{"issue":"18","key":"10.1016\/j.phrs.2024.107410_bib170","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1093\/emboj\/18.18.5099","article-title":"T. Kouzarides, HDAC4 deacetylase associates with and represses the MEF2 transcription factor","volume":"18","author":"Miska","year":"1999","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib171","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1091\/mbc.e08-07-0759","article-title":"A histone deacetylase 4\/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression","volume":"20","author":"Tang","year":"2009","journal-title":"Mol. Biol. Cell"},{"issue":"46","key":"10.1016\/j.phrs.2024.107410_bib172","doi-asserted-by":"crossref","first-page":"33752","DOI":"10.1074\/jbc.M706268200","article-title":"The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming","volume":"282","author":"Cohen","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"Pt 8","key":"10.1016\/j.phrs.2024.107410_bib173","first-page":"2359","article-title":"Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression, Brain: a","volume":"136","author":"Bruneteau","year":"2013","journal-title":"J. Neurol."},{"issue":"5959","key":"10.1016\/j.phrs.2024.107410_bib174","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1181046","article-title":"MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice","volume":"326","author":"Williams","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107410_bib175","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuroscience.2018.03.022","article-title":"Effects of class II-selective histone deacetylase inhibitor on neuromuscular function and disease progression in SOD1-ALS mice","volume":"379","author":"Buonvicino","year":"2018","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib176","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2011.06.003","article-title":"Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis","volume":"231","author":"Yoo","year":"2011","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.phrs.2024.107410_bib177","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2011.61","article-title":"Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders","volume":"1","author":"Tang","year":"2011","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib178","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1021\/acschemneuro.6b00372","article-title":"Expression of HDAC2 but Not HDAC1 transcript is reduced in dorsolateral prefrontal cortex of patients with Schizophrenia","volume":"8","author":"Schroeder","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2024.107410_bib179","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.alcohol.2019.02.005","article-title":"The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal","volume":"78","author":"Chen","year":"2019","journal-title":"Alcohol"},{"issue":"12","key":"10.1016\/j.phrs.2024.107410_bib180","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/WNR.0000000000001693","article-title":"Involvement of 5-HT1A receptor-mediated histone acetylation in the regulation of depression","volume":"32","author":"Zhu","year":"2021","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib181","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1503\/jpn.230054","article-title":"Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia","volume":"49","author":"Mart\u00ednez-Peula","year":"2024","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib182","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.psychres.2009.05.007","article-title":"Association of histone deacetylase genes with schizophrenia in Korean population","volume":"178","author":"Kim","year":"2010","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib183","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1172\/JCI123743","article-title":"PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia","volume":"129","author":"Gilbert","year":"2019","journal-title":"J. Clin. Invest"},{"issue":"23","key":"10.1016\/j.phrs.2024.107410_bib184","doi-asserted-by":"crossref","first-page":"E4686","DOI":"10.1073\/pnas.1613842114","article-title":"HDAC1 links early life stress to schizophrenia-like phenotypes","volume":"114","author":"Bahari-Javan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.phrs.2024.107410_bib185","first-page":"986","article-title":"Epigenetic mechanism of depression","volume":"112","author":"Morinobu","year":"2010","journal-title":"Seishin Shinkeigaku Zasshi"},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib186","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.108.051763","article-title":"The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes","volume":"75","author":"Kundakovic","year":"2009","journal-title":"Mol. Pharm."},{"issue":"17","key":"10.1016\/j.phrs.2024.107410_bib187","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1093\/nar\/gkt590","article-title":"Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition","volume":"41","author":"Lopez-Atalaya","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2024.107410_bib188","article-title":"FDA approves an HDAC inhibitor for Duchenne muscular dystrophy","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib189","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archgenpsychiatry.2011.72","article-title":"P.S. Aisen, Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease","volume":"68","author":"Tariot","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.phrs.2024.107410_bib190","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fneur.2015.00188","article-title":"Changes in the peripheral blood gene expression profile induced by 3\u2009months of valproate treatment in patients with newly diagnosed epilepsy","volume":"6","author":"Rakitin","year":"2015","journal-title":"Front Neurol."},{"issue":"11","key":"10.1016\/j.phrs.2024.107410_bib191","doi-asserted-by":"crossref","DOI":"10.1111\/epi.13114","article-title":"Valproate modulates glucose metabolism in patients with epilepsy after first exposure","volume":"56","author":"Rakitin","year":"2015","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.phrs.2024.107410_bib192","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091301","article-title":"Suberoylanilide hydroxamic acid (SAHA) is a driver molecule of neuroplasticity: implication for neurological diseases","volume":"13","author":"Verrillo","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2024.107410_bib193","doi-asserted-by":"crossref","unstructured":"M.V. Centeno, M.S. Alam, K. Haldar, A.V. Apkarian, Long-range action of an HDAC inhibitor treats chronic pain in a spared nerve injury rat model, bioRxiv (2023).","DOI":"10.1101\/2023.12.13.571583"},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib194","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12017-021-08660-4","article-title":"Repurposing vorinostat for the treatment of disorders affecting brain","volume":"23","author":"Athira","year":"2021","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.phrs.2024.107410_bib195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2015.11.003","article-title":"Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory\/excitatory genes in the frontal cortex of an autism model","volume":"102","author":"Kratsman","year":"2016","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.phrs.2024.107410_bib196","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1037\/0735-7044.121.5.1125","article-title":"Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction","volume":"121","author":"Lattal","year":"2007","journal-title":"Behav. Neurosci."},{"issue":"28","key":"10.1016\/j.phrs.2024.107410_bib197","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib198","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1007\/s12035-016-0149-z","article-title":"HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke","volume":"54","author":"Patnala","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107410_bib199","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3389\/fneur.2019.00663","article-title":"Potential of prebiotic butyrogenic fibers in Parkinson's Disease","volume":"10","author":"Cantu-Jungles","year":"2019","journal-title":"Front Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111772","article-title":"Sodium butyrate causes \u03b1-synuclein degradation by an Atg5-dependent and PI3K\/Akt\/mTOR-related autophagy pathway","volume":"387","author":"Qiao","year":"2020","journal-title":"Exp. Cell Res"},{"issue":"12","key":"10.1016\/j.phrs.2024.107410_bib201","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00726-023-03297-y","article-title":"In the quest for histone deacetylase inhibitors: current trends in the application of multilayered computational methods","volume":"55","author":"Uba","year":"2023","journal-title":"Amino Acids"},{"key":"10.1016\/j.phrs.2024.107410_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176067","article-title":"Novel HDAC inhibitors provide neuroprotection in MPTP-induced Parkinson's disease model of rats","volume":"959","author":"Meka","year":"2023","journal-title":"Eur. J. Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib203","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/ddr.22102","article-title":"Mesenchymal stem cell-derived rapid drug screening system for Alzheimer's disease for the identification of novel drugs","volume":"84","author":"Gamit","year":"2023","journal-title":"Drug Dev. Res"},{"issue":"17","key":"10.1016\/j.phrs.2024.107410_bib204","doi-asserted-by":"crossref","first-page":"17279","DOI":"10.1021\/acsomega.9b01950","article-title":"Crafting carbazole-based vorinostat and tubastatin-a-like histone deacetylase (HDAC) inhibitors with potent in vitro and in vivo neuroactive functions","volume":"4","author":"Reddy","year":"2019","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib205","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/acsmedchemlett.9b00071","article-title":"Novel sustainable-by-design HDAC Inhibitors for the treatment of Alzheimer's Disease","volume":"10","author":"Soares Romeiro","year":"2019","journal-title":"ACS Med Chem. Lett."},{"issue":"11","key":"10.1016\/j.phrs.2024.107410_bib206","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119743","article-title":"Elaboration of the effective multi-target therapeutic platform for the treatment of Alzheimer's disease based on novel monoterpene-derived hydroxamic acids","volume":"24","author":"Aleksandrova","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2024.107410_bib207","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.ajpath.2015.07.006","article-title":"Smoking-induced expression of the GPR15 gene indicates its potential role in chronic inflammatory pathologies","volume":"185","author":"K\u00f5ks","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"17","key":"10.1016\/j.phrs.2024.107410_bib208","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1021\/acschemneuro.3c00358","article-title":"Design, synthesis, and proof of concept of balanced dual inhibitors of butyrylcholinesterase (BChE) and histone deacetylase 6 (HDAC6) for the treatment of Alzheimer's Disease","volume":"14","author":"Wang","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2024.107410_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117178","article-title":"Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC\/AChE inhibitors for Alzheimer's disease","volume":"80","author":"Qin","year":"2023","journal-title":"Bioorg. Med Chem."},{"key":"10.1016\/j.phrs.2024.107410_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103721","article-title":"Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation","volume":"98","author":"Xu","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.phrs.2024.107410_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112193","article-title":"Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease","volume":"192","author":"Tseng","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2024.107410_bib212","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fnagi.2019.00149","article-title":"Taking advantage of the selectivity of histone deacetylases and phosphodiesterase inhibitors to design better therapeutic strategies to treat Alzheimer's Disease","volume":"11","author":"Cuadrado-Tejedor","year":"2019","journal-title":"Front Aging Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib213","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/npp.2016.163","article-title":"A first-in-class small-molecule that acts as a dual inhibitor of HDAC and PDE5 and that rescues hippocampal synaptic impairment in Alzheimer's Disease Mice","volume":"42","author":"Cuadrado-Tejedor","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2024.107410_bib214","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejmech.2018.03.005","article-title":"Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease","volume":"150","author":"Rabal","year":"2018","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.phrs.2024.107410_bib215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13148-015-0142-9","article-title":"Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease","volume":"7","author":"Cuadrado-Tejedor","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.phrs.2024.107410_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104109","article-title":"Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer's disease","volume":"103","author":"He","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2024.107410_bib217","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/cmdc.200900045","article-title":"Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress","volume":"4","author":"Kozikowski","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.phrs.2024.107410_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105724","article-title":"HDAC1\/MAO-B dual inhibitors against Alzheimer's disease: design, synthesis and biological evaluation of N-propargylamine-hydroxamic acid\/o-aminobenzamide hybrids","volume":"122","author":"Yao","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2024.107410_bib219","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00726-023-03249-6","article-title":"Phenolic compounds as histone deacetylase inhibitors: binding propensity and interaction insights from molecular docking and dynamics simulations","volume":"55","author":"Uba","year":"2023","journal-title":"Amino Acids"},{"key":"10.1016\/j.phrs.2024.107410_bib220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.fitote.2018.05.011","article-title":"Biophenols: enzymes (\u03b2-secretase, Cholinesterases, histone deacetylase and tyrosinase) inhibitors from olive (Olea europaea L.)","volume":"128","author":"Omar","year":"2018","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phrs.2024.107410_bib221","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/709108","article-title":"Investigations of curcumin and resveratrol on neurite outgrowth: perspectives on spinal muscular atrophy","volume":"2014","author":"Bora-Tatar","year":"2014","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.phrs.2024.107410_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115746","article-title":"The application of PROTAC in HDAC","volume":"260","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.phrs.2024.107410_bib223","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1111\/bph.13208","article-title":"Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors","volume":"172","author":"Harrison","year":"2015","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib224","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5607\/en.2019.28.4.504","article-title":"HDAC inhibition by valproic acid induces neuroprotection and improvement of PD-like Behaviors in LRRK2 R1441G transgenic mice","volume":"28","author":"Kim","year":"2019","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.phrs.2024.107410_bib225","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuroscience.2011.08.010","article-title":"Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"194","author":"Kidd","year":"2011","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.phrs.2024.107410_bib226","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2024.107410_bib227","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s12640-020-00238-5","article-title":"Butyrate protects against salsolinol-induced toxicity in SH-SY5Y cells: implication for Parkinson's Disease","volume":"38","author":"Getachew","year":"2020","journal-title":"Neurotox. Res"},{"key":"10.1016\/j.phrs.2024.107410_bib228","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbr.2015.05.052","article-title":"Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activity","volume":"291","author":"Sharma","year":"2015","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.phrs.2024.107410_bib229","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","article-title":"Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease","volume":"246","author":"Laurent","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2024.107410_bib230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2015.07.015","article-title":"NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease","volume":"99","author":"Suo","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2024.107410_bib231","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.phrs.2015.11.024","article-title":"Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: therapeutic implications for Parkinson's disease","volume":"103","author":"Pinho","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.phrs.2024.107410_bib232","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/cns.12217","article-title":"Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+","volume":"20","author":"Zhu","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2024.107410_bib233","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/jnc.13070","article-title":"Targeting cyclin D3\/CDK6 activity for treatment of Parkinson's disease","volume":"133","author":"Alqu\u00e9zar","year":"2015","journal-title":"J. Neurochem"},{"key":"10.1016\/j.phrs.2024.107410_bib234","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2021.103642","article-title":"LMK235, a small molecule inhibitor of HDAC4\/5, protects dopaminergic neurons against neurotoxin- and \u03b1-synuclein-induced degeneration in cellular models of Parkinson's disease","volume":"115","author":"Mazzocchi","year":"2021","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.phrs.2024.107410_bib235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbi.2022.02.025","article-title":"G.W. O\u2032Keeffe, Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease","volume":"102","author":"Mazzocchi","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2024.107410_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109841","article-title":"Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson's disease model in rats","volume":"354","author":"El-Saiy","year":"2022","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.phrs.2024.107410_bib237","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mcn.2016.09.003","article-title":"Mechanism for neurotropic action of vorinostat, a pan histone deacetylase inhibitor","volume":"77","author":"Shukla","year":"2016","journal-title":"Mol. Cell Neurosci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107410_bib238","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1476-5381.2011.01575.x","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage","volume":"165","author":"Chen","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"9","key":"10.1016\/j.phrs.2024.107410_bib239","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s11064-014-1241-2","article-title":"Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries","volume":"39","author":"Chen","year":"2014","journal-title":"Neurochem Res."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib240","first-page":"29","article-title":"Design, synthesis, and evaluation of hydroxamic acid-based molecular probes for in vivo imaging of histone deacetylase (HDAC) in brain","volume":"4","author":"Wang","year":"2013","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib241","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13075-019-1834-x","article-title":"Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression","volume":"21","author":"Cleophas","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2024.107410_bib242","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091324","article-title":"Low-dose chidamide treatment displays sex-specific differences in the 3xTg-AD Mouse","volume":"13","author":"Dennison","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib243","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37496-0","article-title":"Evaluation of the orally bioavailable 4-phenylbutyrate-tethered trichostatin A analogue AR42 in models of spinal muscular atrophy","volume":"13","author":"Lumpkin","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2024.107410_bib244","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12974-021-02273-1","article-title":"Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NF\u03baB to promote axonal regeneration and remyelination","volume":"18","author":"Yadav","year":"2021","journal-title":"J. Neuroinflamm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824003554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T21:12:19Z","timestamp":1732741939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824003554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":244,"alternative-id":["S1043661824003554"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107410","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of histone deacetylases and their inhibitors in neurological diseases","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107410"}}